TWI605820B - An herbal composition for improving alcohol intoxication and a use of the herbal composition thereof - Google Patents

An herbal composition for improving alcohol intoxication and a use of the herbal composition thereof Download PDF

Info

Publication number
TWI605820B
TWI605820B TW105124340A TW105124340A TWI605820B TW I605820 B TWI605820 B TW I605820B TW 105124340 A TW105124340 A TW 105124340A TW 105124340 A TW105124340 A TW 105124340A TW I605820 B TWI605820 B TW I605820B
Authority
TW
Taiwan
Prior art keywords
herbal composition
alcoholism
improving
licorice
herbal
Prior art date
Application number
TW105124340A
Other languages
Chinese (zh)
Other versions
TW201808318A (en
Inventor
李世強
劉崇喜
劉怡旻
Original Assignee
康力生技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 康力生技股份有限公司 filed Critical 康力生技股份有限公司
Priority to TW105124340A priority Critical patent/TWI605820B/en
Priority to CN201710647793.XA priority patent/CN107669733B/en
Application granted granted Critical
Publication of TWI605820B publication Critical patent/TWI605820B/en
Publication of TW201808318A publication Critical patent/TW201808318A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

用以改善酒精中毒之中草藥複方組合物及其用途 Herbal compound composition for improving alcoholism and use thereof

本發明係關於一種中草藥複方組合物,特別係一種用以改善酒精中毒之中草藥複方組合物,本發明另關於該中草藥複方組合物用以製備改善酒精中毒藥物之用途。 The invention relates to a Chinese herbal compound composition, in particular to a Chinese herbal compound composition for improving alcoholism, and the invention relates to the use of the Chinese herbal compound composition for preparing an alcohol poisoning medicament.

酒精中毒(alcohol intoxication)又稱為酒醉(drunkenness),係指酒精(乙醇)攝取所造成之生理狀態,舉例而言,低劑量之乙醇攝取會導致多幸福感、皮膚轉紅及舉止不當等狀態,高劑量之乙醇攝取則可能會導致平衡失控、肌肉失調、判斷力受損等,甚至可能會造成昏迷或死亡。 Alcohol intoxication, also known as drunkenness, refers to the physiological state caused by alcohol (ethanol) intake. For example, low-dose ethanol intake can lead to more happiness, skin redness and misbehavior. State, high doses of ethanol intake may lead to loss of balance, muscle disorders, impaired judgment, etc., and may even cause coma or death.

牛樟芝(Antrodia cinnamomea)為台灣特有珍貴藥材,僅生長於台灣保育類之牛樟樹(Cinnamomum kanehirai)的中空芯材內壁,野生牛樟芝含有豐富的三萜類(Triterpenoids),三萜類具有抑制癌症細胞生長、修復肝臟及促進肝功能、降低血脂及血壓、提升免疫能力等功能,對於舒緩酒精中毒所造成之生理狀態亦有所助益;惟,牛樟芝的價格昂貴,不適合作為改善酒精中毒之活性成分的開發,因而仍需開發一種能夠改善酒精中毒之中草藥複方組合物,以改善前述問題。 Antrodia cinnamomea is a unique and precious medicinal material in Taiwan. It is grown only on the inner wall of hollow core material of Cinnamomum kanehirai , which is rich in triterpenoids. Triterpenoids have inhibitory cancer cells. The functions of growing, repairing the liver and promoting liver function, lowering blood lipids and blood pressure, and improving immunity can also help to alleviate the physiological state caused by alcoholism; however, the price of Antrodia camphorata is not suitable as an active ingredient for improving alcoholism. Development, and therefore still need to develop a herbal compound composition that can improve alcoholism to improve the aforementioned problems.

本發明係提供一種中草藥複方組合物,係可以降低改善酒精中毒之活性成份的成本者。 The present invention provides a Chinese herbal compound composition which can reduce the cost of improving the active ingredient of alcoholism.

本發明再提供一種中草藥複方組合物之用途,係作為改善酒精中毒之活性成份者。 The invention further provides a use of a Chinese herbal compound composition as an active ingredient for improving alcoholism.

一種用以改善酒精中毒之中草藥複方組合物,係包含:以重量百分比計為50~75%之一牛樟芝酒萃物及25~50%之一炙甘草酒萃物。 A herbal composition for improving alcoholism, comprising: 50 to 75% by weight of an extract of Antrodia camphorata and 25 to 50% of one of the licorice liquor extracts.

本發明之用以改善酒精中毒之中草藥複方組合物,其中,該牛樟芝酒萃物係萃取自一牛樟芝子實體樣品,且係為由體積百分濃度為95%之一乙醇水溶液所萃取獲得。 The herbal composition for improving alcoholism in the present invention, wherein the extract of Antrodia camphorata is extracted from a solid sample of Antrodia camphorata, and is obtained by extracting an aqueous solution of ethanol having a volume percentage of 95%.

本發明之用以改善酒精中毒之中草藥複方組合物,其中,該炙甘草酒萃物係萃取自經蜜烘製之一甘草根部樣品,且係為由體積百分濃度為95%之一乙醇水溶液所萃取獲得。 The herbal composition for improving alcoholism in the present invention, wherein the extract of the licorice liquor is extracted from a licorice root sample which is subjected to honey baking, and is an ethanol aqueous solution having a volume percent concentration of 95%. Extracted to obtain.

本發明之用以改善酒精中毒之中草藥複方組合物,其中,該炙甘草酒萃物係由包含以下步驟之方法所製得:以4:1之重量比混合該甘草根部樣品及一煉蜜;將該甘草根部樣品及該煉蜜之混合物共同於110~130℃下悶潤4~5小時,並於110~130℃下進行翻炒;及以該乙醇水溶液萃取該經蜜烘製之一甘草根部樣品。 The herbal composition for improving alcoholism in the present invention, wherein the licorice extract is obtained by a method comprising the steps of: mixing the licorice root sample and a condensed honey in a weight ratio of 4:1; Mixing the licorice root sample and the nectar mixture together at 110-130 ° C for 4-5 hours, and frying at 110-130 ° C; and extracting the honey-dried licorice with the aqueous ethanol solution Root sample.

一種如上述之中草藥複方組合物的用途,係應用於製備改善酒精中毒的藥物,該中草藥複方組合物係投予一所需個體,以改善該所需升物體之酒精中毒現象。 A use of the above-mentioned herbal composition of the above-mentioned herbal medicine is applied to the preparation of a medicament for improving alcoholism, and the herbal composition is administered to a desired individual to improve the alcohol poisoning phenomenon of the desired ascending object.

本發明之中草藥複方組合物的用途,其中,該中草藥複方組合物係於該所需個體攝取乙醇之20~40分鐘前投予該所需個體,且每次投予劑量為10~40毫克/公斤體重;較佳地,該中草藥複方組合物係於該所需個體攝取乙醇之30分鐘前投予該所需個體,且每次投予劑量為30毫克/公斤體重。 The use of the herbal composition of the present invention, wherein the Chinese herbal compound composition is administered to the desired individual 20 to 40 minutes before the intake of the desired individual, and the dosage is 10-40 mg per administration. Preferably, the herbal composition is administered to the individual in need thereof 30 minutes prior to the ingestion of the desired individual, and each dose is 30 mg/kg body weight.

本發明之用以改善酒精中毒之中草藥複方組合物,係藉由炙甘草酒萃物的添加,降低改善酒精中毒之活性成份的成本,可以達成提升 改善酒精中毒之活性成份的性價比的功效。 The herbal composition for improving alcoholism in the present invention is achieved by reducing the cost of improving the active ingredient of alcoholism by adding the extract of licorice liquor. Improve the cost-effectiveness of active ingredients in alcoholism.

本發明之中草藥複方組合物的用途,係藉由牛樟芝酒萃物及炙甘草酒萃物的組成配比,提升細胞中之醇脫氫酶的活性,加速代謝攝取之乙醇,如此可以改善乙醇攝取所造成之運動協調性、睡眠時間等問題,為本發明之功效。 The use of the herbal composition of the present invention is to increase the activity of alcohol dehydrogenase in cells and accelerate the metabolic intake of ethanol by using the composition ratio of the extract of Antrodia camphorata and the extract of Zhigancao wine, thereby improving ethanol intake. The problems of exercise coordination, sleep time and the like are the effects of the present invention.

本發明之中草藥複方組合物的用途,係藉由牛樟芝酒萃物及炙甘草酒萃物的組成配比,提升細胞中之抗氧化酵素的活性,使肝臟細胞得以抵抗自由基的傷害,而可以達成改善乙醇攝取所造成的肝損傷之功效。 The use of the herbal composition of the present invention is to increase the activity of antioxidant enzymes in the cells by the composition ratio of the extract of the burdock wine and the extract of the licorice liquor, so that the liver cells can resist the damage of free radicals, and Achieve the effect of improving liver damage caused by ethanol intake.

第1圖:第B0~B3組小鼠之相對跌落旋轉棒歷時的柱狀圖。 Figure 1: Bar graph of the relative drop rotation of the B0~B3 mice over time.

第2圖:第B0~B3組小鼠之相對回復翻正反射需時的柱狀圖。 Figure 2: A histogram of the relative recovery of Orthonormal Reflex in mice in Groups B0 to B3.

第3圖:第C0~C3組小鼠之相對細胞中之醇脫氫酶活性的柱狀圖。 Figure 3: Bar graph of alcohol dehydrogenase activity in relative cells of mice in Groups C0 to C3.

第4圖:第D0~D3組小鼠之相對血清中之榖胱甘肽S轉移酶活性的柱狀圖。 Figure 4: Bar graph of glutathione S transferase activity in the relative serum of mice in groups D0 to D3.

第5圖:第D0~D3組小鼠之相對細胞中之穀胱甘肽過氧化物酶活性的柱狀圖。 Figure 5: Bar graph of glutathione peroxidase activity in relative cells of mice in groups D0 to D3.

為讓本發明之上述及其他目的、特徵及優點能更明顯易懂,下文特舉本發明之較佳實施例,並配合所附圖式,作詳細說明如下:本發明之一實施例的中草藥複方組合物係包含:以重量百分比計為50~75%之一牛樟芝酒萃物及25~50%之一炙甘草酒萃物,藉由該牛樟芝酒萃物及該炙甘草酒萃物之組成配比,可以改善所需個體之酒精中毒現象。 The above and other objects, features and advantages of the present invention will become more <RTIgt; The compound composition comprises: 50% to 75% by weight of an extract of Antrodia camphorata wine and 25~50% of one of the licorice liquor extracts, wherein the extract of the Antrodia camphorata wine and the extract of the licorice liquor The ratio can improve the alcoholism of the individual.

該牛樟芝酒萃物及該炙甘草酒萃物之萃取方法係為本發明 所屬技術領域中具有通常知識者依需求所能夠調整,於此不加以設限。詳而言之,該牛樟芝酒萃物係萃取自一牛樟芝子實體樣品,例如由體積百分濃度為95%之一乙醇水溶液所萃取獲得;又,該炙甘草酒萃物係萃取自一蜜炙甘草根部樣品,例如由體積百分濃度為95%之一乙醇水溶液所萃取獲得,該蜜炙甘草根部樣品則可以由包含以下步驟之方法所製得:舉例而言,以4:1之重量比混合一甘草根部樣品及一煉蜜(refined honey,將蜂蜜於116~119℃下加熱至含水量為10~13%所獲得),並將該甘草根部樣品及該煉蜜之混合物共同於110~130℃下悶潤4~5小時,最終於110~130℃下進行翻炒。於本實施例中,係將該牛樟芝子實體樣品及該蜜炙甘草根部樣品(共500g)進行混合後,以1L之乙醇水溶液(體積百分濃度為95%)於70~90℃下進行萃取10小時,續經過真空過濾、減壓濃縮及冷凍乾燥後,即可以獲得該中草藥複方組合物。 The extraction method of the Antrodia camphorata wine extract and the extract of the Licorice wine is the invention Those having ordinary knowledge in the art can adjust according to requirements, and are not limited herein. In detail, the extract of Antrodia camphorata is extracted from a solid sample of Antrodia camphorata, for example, extracted by a 95% by volume aqueous solution of ethanol; and the extract of the Licorice extract is extracted from a candied fruit. The licorice root sample is obtained, for example, by extracting from a 95% by volume aqueous solution of ethanol, and the candied licorice root sample can be obtained by a method comprising the following steps: for example, a weight ratio of 4:1 Mixing a licorice root sample and a refined honey (heated at 116-119 ° C to a water content of 10 to 13%), and the licorice root sample and the mixture of the nectar are combined at 110~ Stir at 130 ° C for 4 to 5 hours, and finally stir fry at 110 ~ 130 ° C. In this embodiment, the A. angustifolia fruit body sample and the candied licorice root sample (500 g in total) are mixed, and then extracted with 1 L of an aqueous ethanol solution (95% by volume) at 70 to 90 ° C. The Chinese herbal compound composition can be obtained after 10 hours, followed by vacuum filtration, concentration under reduced pressure, and lyophilization.

本發明之中草藥複方組合物係可以有效改善乙醇攝取所造成之生理狀態,因而係能夠作為一種改善酒精中毒之活性成分,例如可以將該中草藥複方組合物應用於製備改善酒精中毒之藥物或保健食品,該中草藥複方組合物與醫藥學上可以接受之載劑或賦形劑組合形成一醫藥組合物,其中,該中草藥複方組合物係可以製備成任何方便食用之型式,如錠劑、膠囊、粉劑、粒劑或液劑等,或者將該中草藥複方組合物與其他食品或飲料組合,以一適於食用之樣態供生物體以口服方式服用。 The herbal composition of the present invention can effectively improve the physiological state caused by ethanol intake, and thus can be used as an active ingredient for improving alcoholism. For example, the Chinese herbal compound composition can be applied to prepare a drug or health food for improving alcoholism. The Chinese herbal compound composition is combined with a pharmaceutically acceptable carrier or excipient to form a pharmaceutical composition, wherein the Chinese herbal compound composition can be prepared into any convenient form such as a tablet, a capsule or a powder. , granules or liquids, etc., or the combination of the Chinese herbal compound and other foods or beverages, for oral administration to the organism in a form suitable for consumption.

又,該中草藥複方組合物係可以供投予一所需個體,例如於該所需個體攝取乙醇之20~40分鐘前投予該所需個體,且每次投予劑量為10~40毫克/公斤體重,較佳可以於該所需個體攝取乙醇之30分鐘前投予該所需個體,且每次投予劑量為30毫克/公斤體重,使該中草藥複方組合物所含有之活性成分得以於該所需個體體內作用,而可以改善該所需個體之酒精中毒現象。 In addition, the Chinese herbal compound composition can be administered to a desired individual, for example, 20 to 40 minutes before the desired individual takes in ethanol, and the dose is 10-40 mg per dose. The kilogram of body weight, preferably, can be administered to the desired individual 30 minutes before the ingestion of the desired individual, and the dosage is 30 mg/kg body weight per administration, so that the active ingredient contained in the Chinese herbal compound composition can be obtained. The desired individual acts in the body and can improve the alcoholism of the desired individual.

以下係製備包含不同配比之牛樟芝酒萃物及炙甘草酒萃物的本發明中草藥複方組合物,續以行為測試及生理活性測定證實本發明中草藥複方組合物確實具有改善酒精中毒現象之活性: The following is a preparation of the Chinese herbal compound composition containing the different ratios of the extract of Antrodia camphorata and the extract of Zhigancao wine, and the behavioral test and the physiological activity test are successively confirmed that the Chinese herbal compound composition of the invention has the activity of improving alcoholism:

(A)中草藥複方組合物之製備 (A) Preparation of Chinese herbal compound composition

本試驗中,係取如第1表所示之牛樟芝子實體樣品及蜜炙甘草根部樣品(共500g),以1L之乙醇水溶液(體積百分濃度為95%)進行萃取,以獲得本試驗第A1~A3組之中草藥複方組合物;另以甘草根部樣品取代第A1~A3組之蜜炙甘草根部樣品,混合牛樟芝子實體樣品後,同樣經乙醇水溶液進行萃取獲得本試驗第A1’~A3’組之中草藥複方組合物;此外,以1L之乙醇水溶液(體積百分濃度為95%)萃取500g之牛樟芝子實體樣品,以獲得作為對照組之牛樟芝酒萃物(第A0組)。 In this test, a sample of the body of A. angustifolia and a root sample of candied licorice (500 g) as shown in Table 1 were taken, and extracted with 1 L of an aqueous ethanol solution (95% by volume) to obtain the first test. A1~A3 group of Chinese herbal compound composition; the licorice root sample was substituted for the root sample of candied licorice in group A1~A3, and the mixture was extracted with ethanol aqueous solution to obtain the first A1'~A3' of the experiment. The herbal composition of the group was extracted; in addition, 500 g of the extract of Antrodia camphorata fruit body was extracted with 1 L of an aqueous ethanol solution (95% by volume) to obtain an extract of Antrodia camphorata as a control group (Group A0).

後續試驗係選用購自財團法人國家實驗研究院國家實驗動物中心之ICR雄性小鼠(體重介於18~22克之間)及Wistar雄性大鼠(8週齡以上,體重介於180~190克之間)作為試驗動物。前述試驗動物係飼養於大仁科技大學動物中心,維持室溫為24±2℃之動物室(光照時間與黑暗時間各為12小時),且可以自由進食及飲水。 The follow-up trials used ICR male mice (between 18 and 22 grams) purchased from the National Experimental Animal Center of the National Experimental Research Institute, and Wistar male rats (8 weeks old and above, weighing between 180 and 190 grams). ) as a test animal. The aforementioned test animals were housed in the Animal Center of Daren University of Science and Technology, and maintained an animal room at room temperature of 24 ± 2 ° C (12 hours of light time and dark time), and were free to eat and drink.

(B)行為測試 (B) Behavioral testing

本試驗係以旋轉棒試驗(rotarod test)觀察前述ICR雄性小鼠的運動協調性(motor coordination),係使各組ICR小鼠經口攝取如第2 表之中草藥複方組合物(攝取劑量為30mg/kg),續於30分鐘經口攝取乙醇水溶液(體積百分濃度為30%,攝取劑量為100mL/kg),接著迫使各組ICR小鼠於旋轉棒(rotarod,XZC-4B,16rpm)上進行反向運動,紀錄各組ICR小鼠跌落旋轉棒歷時(latency to fall)。 In this test, the motor coordination of the aforementioned ICR male mice was observed by a rotarod test, and the oral intake of each group of ICR mice was as follows. The herbal composition of the herbal medicine (intake dose of 30 mg/kg) was orally administered with an aqueous solution of ethanol (30% by volume, and the ingested dose was 100 mL/kg) for 30 minutes, and then forced each group of ICR mice to rotate. Reverse motion was performed on rods (rotarod, XZC-4B, 16 rpm) and each group of ICR mice was recorded for latency to fall.

又,另以僅經口攝取乙醇水溶液(體積百分濃度為30%,攝取劑量為100mL/kg)之ICR小鼠之跌落旋轉棒歷時作為正控制組,僅經口攝取蒸餾水(攝取劑量為100mL/kg)之ICR小鼠之跌落旋轉棒歷時作為負控制組,並以如下之式一計算各組ICR小鼠之相對跌落旋轉棒歷時(%),結果如第1圖所示。 In addition, the drop rotarod of ICR mice which was only taken orally in an aqueous solution of ethanol (30% by volume, and the ingested dose was 100 mL/kg) was used as a positive control group, and only distilled water was orally taken (the ingestion dose was 100 mL). /kg) The ITR mouse's drop rotation rod duration was used as the negative control group, and the relative drop rotation rod duration (%) of each group of ICR mice was calculated as shown in the following figure, and the results are shown in Fig. 1.

(試驗組-正控制組)/(負控制組-正控制組)×100% (式一) (test group - positive control group) / (negative control group - positive control group) × 100% (Formula 1)

請參照第1圖所示,預先經口攝取第A0之牛樟芝酒萃物及第A1~A3組之中草藥複方組合物的第B0~B3組ICR小鼠的跌落旋轉棒歷時均長於僅經口攝取乙醇水溶液之正控制組,其中又以預先經口攝取第A2、A3組之中草藥複方萃取物的第B2、B3組ICR小鼠的相對跌落旋轉棒歷時可以分別延長達約41%、43%,顯示第A2、A3組之中草藥複方萃 取物對於改善乙醇攝取所造成之運動協調異常的效果最為顯著;此外,相較於第A0組之牛樟芝酒萃物,萃取自牛樟芝子實體樣品及甘草根部樣品的第A1’~A3’組中草藥複方萃取物對於改善乙醇攝取所造成之運動協調異常之效果較差,故不再進行後續試驗。 Please refer to Fig. 1 for the above-mentioned oral ingestion of the extract of A. serrata and the group A0~A3 of the A1~A3 group of ICR mice. The positive control group of the aqueous ethanol solution, in which the relative drop rotation rods of the B2 and B3 groups of the A2 and B3 groups of the herbal extracts of the A2 and A3 groups were ingested for about 41% and 43%, respectively. Display the combination of herbal extracts in group A2 and group A3 The effect of extracting materials on the improvement of motor coordination abnormalities caused by ethanol intake was the most significant; in addition, compared with the extract of Antrodia camphorata in Group A0, the A1'~A3' group of Chinese herbal medicines extracted from the sample of A. angustifolia and the roots of licorice roots Compound extracts have a poor effect on improving motor coordination abnormalities caused by ethanol uptake, so no further tests are performed.

續以翻正反射試驗(righting reflex test)觀察前述ICR雄性小鼠的睡眠時間(sleep time),係使各組ICR小鼠經口攝取如第2表之中草藥複方組合物(攝取劑量為30mg/kg),續於30分鐘經口攝取乙醇水溶液(體積百分濃度為55%,攝取劑量為100mL/kg),接著於各組ICR小鼠翻正反射消失(loss of righting reflex)後,將各組ICR小鼠背部朝下置於籠內,紀錄各組ICR小鼠回復翻正反射(regain of righting reflex)需時。 The sleep time of the aforementioned ICR male mice was observed by the right reflex test, and the ICR mice of each group were orally ingested as in the second table of the herbal compound composition (the ingestion dose was 30 mg/ Kg), continued to take an aqueous solution of ethanol (55% by volume, ingestion dose of 100 mL/kg) for 30 minutes, followed by loss of righting reflex in each group of ICR mice. Group ICR mice were placed face down in the cage and the time to regain of righting reflex was recorded for each group of ICR mice.

此外,另以僅經口攝取乙醇水溶液(體積百分濃度為55%,攝取劑量為100mL/kg)之ICR小鼠之回復翻正反射需時作為正控制組,僅經口攝取蒸餾水(攝取劑量為100mL/kg)之ICR小鼠之回復翻正反射需時作為負控制組,並以如下之式二計算各組ICR小鼠之回復翻正反射需時(%),結果如第2圖所示。 In addition, in the case of ICR mice that only received oral ethanol solution (55% by volume, ingestion dose of 100 mL/kg), the time of returning regurgitation was taken as the positive control group, and only distilled water was taken orally (intake dose). The response of the ICR mice to 100 mL/kg) was taken as the negative control group, and the time required to restore the Orthonormal reflex of each group of ICR mice was calculated as the following formula (2). The results are shown in Fig. 2. Show.

(試驗組-負控制組)/(正控制組-負控制組)×100% (式二) (test group - negative control group) / (positive control group - negative control group) × 100% (Formula 2)

請參照第2圖所示,預先經口攝取第A0之牛樟芝酒萃物及第A1~A3組之中草藥複方組合物的第B0~B3組ICR小鼠的回復翻正反射需時均短於僅經口攝取乙醇水溶液之正控制組,其中又以預先經口攝取第A2、A3組之中草藥複方萃取物的第B2、B3組ICR小鼠的回復翻正反射需時可以分別縮短達約49%、42%,顯示第A2、A3組之中草藥複方萃取物對於改善乙醇攝取所造成之睡眠時間延長現象的效果最為顯著。 Referring to Fig. 2, the response to the anteroposterior reflex of the B0~B3 ICR mice of the A0 yoghurt extract and the A1~A3 medicinal compound composition in advance is shorter than the time only. The positive control group for oral intake of ethanol aqueous solution, in which the anterior reflexes of the B2 and B3 groups of the A2 and B3 groups of the A2 and A3 groups of the herbal extracts of the A2 group and the A3 group can be shortened by about 49%, respectively. 42% showed that the herbal extracts of the A2 and A3 groups had the most significant effect on improving the sleep time caused by ethanol intake.

(C)生理活性測定 (C) Determination of physiological activity

乙醇攝取後會經由血液進入肝臟,續由醇脫氫酶(alcohol dehydrogenase,簡稱ADH)氧化成為乙醛(acetaldehyde),再由乙醛脫氫 酶(acetaldehyde dehydrogenase,簡稱ALDH)轉化為乙酸(acetic acid),故能夠以細胞中之醇脫氫酶的活性作為乙醇代謝能力的指標,本試驗係使各組Wistar大鼠經口攝取如第3表之中草藥複方組合物(攝取劑量為30mg/kg),續於30分鐘經口攝取乙醇水溶液(體積百分濃度為40%,攝取劑量為2mL/kg),接著量測各組Wistar大鼠之醇脫氫酶活性。 After ingesting ethanol, it will enter the liver via blood, and will continue to be oxidized by alcohol dehydrogenase (ADH) to acetaldehyde, and then dehydrogenated by acetaldehyde. The enzyme (acetaldehyde dehydrogenase, ALDH for short) is converted into acetic acid, so the activity of alcohol dehydrogenase in cells can be used as an indicator of ethanol metabolism. This experiment is to make oral intake of each group of Wistar rats. The herbal composition of the herbal medicine (intake dose of 30 mg/kg) was orally administered with an aqueous solution of ethanol (40% by volume, 2 mL/kg of the ingestion dose) for 30 minutes, and then the Wistar rats of each group were measured. Alcohol dehydrogenase activity.

同時以僅經口攝取乙醇水溶液(體積百分濃度為40%,攝取劑量為2mL/kg)之Wistar大鼠之醇脫氫酶活性作為正控制組,僅經口攝取蒸餾水(攝取劑量為2mL/kg)之Wistar大鼠之醇脫氫酶活性作為負控制組,並以如下之式三計算各組Wistar大鼠之相對醇脫氫酶活性(%),結果如第3圖所示。 At the same time, the alcohol dehydrogenase activity of Wistar rats, which only received oral ethanol solution (40% by volume, and the ingestion dose was 2 mL/kg), was used as a positive control group, and only distilled water was orally administered (intake dose was 2 mL/ The alcohol dehydrogenase activity of Wistar rats of kg) was used as a negative control group, and the relative alcohol dehydrogenase activity (%) of each group of Wistar rats was calculated by the following formula 3, and the results are shown in Fig. 3.

(試驗組-正控制組)/(負控制組-正控制組)×100% (式三) (test group - positive control group) / (negative control group - positive control group) × 100% (Formula 3)

請參照第3圖所示,預先經口攝取第A0之牛樟芝酒萃物及第A1~A3組之中草藥複方組合物的第C0~C3組Wistar大鼠的醇脫氫酶活性均大於僅經口攝取乙醇水溶液之正控制組,其中又以預先經口攝取第A2、A3組之中草藥複方萃取物的第C2、C3組Wistar大鼠的醇脫氫酶活性可以分別提升達約64%、88%,顯示第A2、A3組之中草藥複方萃取物之攝取可以有效提升細胞中之醇脫氫酶的活性,進而可以加速乙醇於體內的代謝。 Please refer to Figure 3 for the alcohol dehydrogenase activity of the C0~C3 Wistar rats in the A0 to C3 group and the A1~A3 group in the A1~A3 group. In the positive control group of the aqueous solution of ethanol, the alcohol dehydrogenase activity of the C2 and C3 groups of the A2 and A3 groups of the herbal extracts of the A2 and A3 groups can be increased by about 64% and 88%, respectively. It shows that the intake of the herbal extracts of the A2 and A3 groups can effectively increase the activity of the alcohol dehydrogenase in the cells, thereby accelerating the metabolism of ethanol in the body.

(D)肝保護效果 (D) liver protection effect

此外,乙醇攝取為造成肝損傷之原因,故使各組Wistar大鼠經口攝取如第4表之中草藥複方組合物(攝取劑量為30mg/kg),續於30分鐘經口攝取乙醇水溶液(體積百分濃度為40%,攝取劑量為2mL/kg),接著量測各組Wistar大鼠之血清中之榖胱甘肽S轉移酶(glutathione S-transferase,簡稱GST)活性及細胞中之穀胱甘肽過氧化物酶(glutathione peroxidase,簡稱GSH-PX)活性。 In addition, ethanol intake is the cause of liver damage, so each group of Wistar rats was orally ingested, such as the herbal composition of the fourth table (intake dose of 30 mg / kg), continued to take oral ethanol solution (volume) for 30 minutes. The percentage concentration was 40%, the ingestion dose was 2 mL/kg), and then the glutathione S-transferase (GST) activity in the serum of each group of Wistar rats and the glutathion in the cells were measured. Glutathione peroxidase (GSH-PX) activity.

本試驗同以僅經口攝取乙醇水溶液(體積百分濃度為40%,攝取劑量為2mL/kg)之Wistar大鼠之榖胱甘肽S轉移酶活性(或穀胱甘肽過氧化物酶活性)作為正控制組,僅經口攝取蒸餾水(攝取劑量為2mL/kg)之Wistar大鼠之榖胱甘肽S轉移酶活性(或穀胱甘肽過氧化物酶活性)作為負控制組,並以如下之式四計算各組Wistar大鼠之相對榖胱甘肽S轉移酶活性(%)及以如下之式五計算各組Wistar大鼠之相對穀胱甘肽過氧化物酶活性(%),結果分別如第4、5圖所示。 This test is the same as glutathione S-transferase activity (or glutathione peroxidase activity) in Wistar rats with oral ethanol (40% by volume, 2 mL/kg). As a positive control group, glutathione S transferase activity (or glutathione peroxidase activity) of Wistar rats, which only received distilled water (intake dose of 2 mL/kg), was used as a negative control group. The relative glutathione S transferase activity (%) of each group of Wistar rats was calculated by the following formula 4 and the relative glutathione peroxidase activity (%) of each group of Wistar rats was calculated as follows: The results are shown in Figures 4 and 5, respectively.

(試驗組-負控制組)/(正控制組-負控制組)×100% (式四) (test group - negative control group) / (positive control group - negative control group) × 100% (Formula 4)

(試驗組-正控制組)/(負控制組-正控制組)×100% (式五) (test group - positive control group) / (negative control group - positive control group) × 100% (Equation 5)

榖胱甘肽S轉移酶則為肝臟解毒機能(detoxification)之重要酵素,於肝臟受損時,榖胱甘肽S轉移酶會釋放進入血液,因而血清中 之榖胱甘肽S轉移酶活性的上升可以作為肝臟受損的指標,因而如第4圖所示,該第A2、A3組之中草藥複方萃取物之攝取可以有效降低血清中之榖胱甘肽S轉移酶的活性,顯示該第A2、A3組之中草藥複方萃取物之攝取可以改善乙醇攝取所造成的肝損傷(liver damage)。 Glutathione S transferase is an important enzyme for detoxification of the liver. When the liver is damaged, glutathione S transferase is released into the blood, thus in the serum. The increase in glutathione S transferase activity can be used as an indicator of liver damage, so as shown in Fig. 4, the intake of the herbal extract of the A2 and A3 groups can effectively reduce glutathione in serum. The activity of the S-transferase showed that the intake of the herbal extract of the A2 and A3 groups improved the liver damage caused by the ethanol intake.

此外,另請參照第5圖所示,該第A2、A3組之中草藥複方萃取物之攝取亦可以有效提升細胞中之穀胱甘肽過氧化物酶活性,穀胱甘肽過氧化物酶為保護生物體免於氧化傷害(oxidative damage)之重要酵素,顯示該第A2、A3組之中草藥複方萃取物之攝取可能係藉由提升抗氧化酵素之活性,使肝臟細胞得以抵抗自由基的傷害,而可以改善乙醇攝取所造成的肝損傷。 In addition, as shown in Fig. 5, the intake of the herbal extracts of the A2 and A3 groups can also effectively increase the activity of glutathione peroxidase in the cells, and glutathione peroxidase is An important enzyme that protects organisms from oxidative damage, indicating that the intake of herbal extracts in Groups A2 and A3 may increase the activity of antioxidant enzymes, so that liver cells can resist free radical damage. It can improve liver damage caused by ethanol intake.

綜合上述,本發明之用以改善酒精中毒之中草藥複方組合物,係藉由炙甘草酒萃物的添加,降低改善酒精中毒之活性成份的成本,可以達成提升改善酒精中毒之活性成份的性價比的功效。 In summary, the herbal composition for improving alcoholism in the present invention reduces the cost of improving the active ingredient of alcoholism by adding the extract of licorice liquor, and can achieve the cost performance of improving the active ingredient of alcoholism. efficacy.

再者,本發明之中草藥複方組合物的用途,係藉由牛樟芝酒萃物及炙甘草酒萃物的組成配比,提升細胞中之醇脫氫酶的活性,加速代謝攝取之乙醇,如此可以改善乙醇攝取所造成之運動協調性、睡眠時間等問題,為本發明之功效。 Furthermore, the use of the herbal composition of the present invention is to increase the activity of the alcohol dehydrogenase in the cell and accelerate the metabolic intake of ethanol by using the composition ratio of the extract of the burdock wine and the extract of the licorice liquor. Improving the coordination of exercise caused by ethanol intake, sleep time and the like are the effects of the present invention.

此外,本發明之中草藥複方組合物的用途,係藉由牛樟芝酒萃物及炙甘草酒萃物的組成配比,提升細胞中之抗氧化酵素的活性,使肝臟細胞得以抵抗自由基的傷害,而可以達成改善乙醇攝取所造成的肝損傷之功效。 In addition, the use of the herbal composition of the present invention is to increase the activity of the antioxidant enzymes in the cells by the composition ratio of the extract of the burdock wine and the extract of the licorice liquor, so that the liver cells can resist the damage of free radicals. The effect of improving liver damage caused by ethanol intake can be achieved.

雖然本發明已利用上述較佳實施例揭示,然其並非用以限定本發明,任何熟習此技藝者在不脫離本發明之精神和範圍之內,相對上述實施例進行各種更動與修改仍屬本發明所保護之技術範疇,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 While the invention has been described in connection with the preferred embodiments described above, it is not intended to limit the scope of the invention. The technical scope of the invention is protected, and therefore the scope of the invention is defined by the scope of the appended claims.

Claims (7)

一種用以改善酒精中毒之中草藥複方組合物,係包含:以重量百分比計為50~75%之一牛樟芝酒萃物及25~50%之一炙甘草酒萃物。 A herbal composition for improving alcoholism, comprising: 50 to 75% by weight of an extract of Antrodia camphorata and 25 to 50% of one of the licorice liquor extracts. 如申請專利範圍第1項所述之用以改善酒精中毒之中草藥複方組合物,其中,該牛樟芝酒萃物係萃取自一牛樟芝子實體樣品,且係為由體積百分濃度為95%之一乙醇水溶液所萃取獲得。 The herbal composition for improving alcoholism according to the first aspect of the patent application, wherein the extract of the Antrodia camphorata is extracted from a sample of the body of the Antrodia camphorata, and the volume is 95% by volume. Extracted from an aqueous ethanol solution. 如申請專利範圍第1項所述之用以改善酒精中毒之中草藥複方組合物,其中,該炙甘草酒萃物係萃取自一蜜炙甘草根部樣品,且係為由體積百分濃度為95%之一乙醇水溶液所萃取獲得。 The herbal composition for improving alcoholism, as described in claim 1, wherein the extract of the licorice liquor is extracted from a root sample of a candied licorice, and the concentration is 95% by volume. It is obtained by extraction with an aqueous solution of ethanol. 如申請專利範圍第3項所述之用以改善酒精中毒之中草藥複方組合物,其中,該蜜炙甘草根部樣品係由包含以下步驟之方法所製得:以4:1之重量比混合一甘草根部樣品及一煉蜜;及將該甘草根部樣品及該煉蜜之混合物共同於110~130℃下悶潤4~5小時,並於110~130℃下進行翻炒。 The herbal composition for improving alcoholism according to the third aspect of the patent application, wherein the candied licorice root sample is obtained by the method comprising the steps of: mixing a licorice in a weight ratio of 4:1; The root sample and a sweetened honey; and the mixture of the licorice root sample and the sweetened honey together are simmered at 110-130 ° C for 4-5 hours, and the stir-fry is performed at 110-130 ° C. 一種如申請專利範圍第1~4項之任一項所述之中草藥複方組合物的用途,係應用於製備改善酒精中毒的藥物,該中草藥複方組合物係投予一所需個體,以改善該所需升物體之酒精中毒現象。 The use of the herbal composition according to any one of claims 1 to 4 for the preparation of a medicament for improving alcoholism, wherein the herbal composition is administered to a desired individual to improve the Alcoholism in the required lifting object. 如申請專利範圍第5項所述之中草藥複方組合物的用途,其中,該中草藥複方組合物係於該所需個體攝取酒精之20~40分鐘前投予該所需個體,且每次投予劑量為10~40毫克/公斤體重。 The use of the herbal composition according to claim 5, wherein the Chinese herbal compound composition is administered to the desired individual 20 to 40 minutes before the alcohol intake of the desired individual, and each time the administration is performed. The dose is 10~40 mg/kg body weight. 如申請專利範圍第6項所述之中草藥複方組合物之用途,其中,該中草藥複方組合物係於該所需個體攝取酒精之30分鐘前投予該所需個體,且每次投予劑量為30毫克/公斤體重。 The use of the herbal composition according to claim 6, wherein the herbal composition is administered to the individual required 30 minutes before the alcohol intake of the desired individual, and the dose is administered each time. 30 mg / kg body weight.
TW105124340A 2016-08-01 2016-08-01 An herbal composition for improving alcohol intoxication and a use of the herbal composition thereof TWI605820B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW105124340A TWI605820B (en) 2016-08-01 2016-08-01 An herbal composition for improving alcohol intoxication and a use of the herbal composition thereof
CN201710647793.XA CN107669733B (en) 2016-08-01 2017-08-01 Chinese herbal medicine compound composition for improving alcoholism and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW105124340A TWI605820B (en) 2016-08-01 2016-08-01 An herbal composition for improving alcohol intoxication and a use of the herbal composition thereof

Publications (2)

Publication Number Publication Date
TWI605820B true TWI605820B (en) 2017-11-21
TW201808318A TW201808318A (en) 2018-03-16

Family

ID=61023292

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105124340A TWI605820B (en) 2016-08-01 2016-08-01 An herbal composition for improving alcohol intoxication and a use of the herbal composition thereof

Country Status (2)

Country Link
CN (1) CN107669733B (en)
TW (1) TWI605820B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI783217B (en) * 2020-03-18 2022-11-11 綠茵生技股份有限公司 Uses of Antrodia Cinnamomea for Hangover and/or Increase Alcohol Metabolism
CN111956700A (en) * 2020-08-27 2020-11-20 扬州大学 Antrodia camphorata anti-alcohol pill and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200745338A (en) * 2006-06-07 2007-12-16 Jian-Min Weng Method for producing Antrodia camphorate Vigna radiate enzyme capable of enhancing human body in counteracting virus, bacteria-degraded chemical toxin and toxin from food
TW201215399A (en) * 2010-10-06 2012-04-16 Joben Bio Medical Co Ltd Combination of sesamin with A. camphoratum extract using in prophylaxis of acute hepatitis
TWM467624U (en) * 2013-02-22 2013-12-11 Yungpeng Biotechnology Co Ltd Drink container of antrodia cinnamomea for reducing alcohol level after alcohol consumption and awakening consciousness
TWM478479U (en) * 2013-12-10 2014-05-21 Miyuan Biotech Co Ltd Embedding structure of Antrodia cinnamomea particle for removing alcohol to prevent hangover
CN103859366B (en) * 2014-03-30 2015-10-28 南陵县铭泽玉竹种植专业合作社 A kind of preparation method of instant four mushroom composite nutrition powders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BMC Complementary and Alternative Medicine,2016,Vol.16,no.19 *
牛樟芝取用子實體 具保肝解酒功效,自由時報2007-03-02 *

Also Published As

Publication number Publication date
CN107669733B (en) 2021-01-12
CN107669733A (en) 2018-02-09
TW201808318A (en) 2018-03-16

Similar Documents

Publication Publication Date Title
KR102107387B1 (en) Beverage composition for treating hangover comprising black ginseng extact
JP6355689B2 (en) Pharmaceutical composition for preventing or treating liver fibrosis or non-alcoholic fatty liver
JP6462918B2 (en) Phytoecdysone for use in stabilizing weight after a weight loss diet
TWI605820B (en) An herbal composition for improving alcohol intoxication and a use of the herbal composition thereof
KR101675064B1 (en) A composition comprising the complex extract for enhancing power of exercise performance and promoting physical stamina
KR20020092082A (en) Tonic composition
WO2016141775A1 (en) Uses of jilin ginseng oligopeptide in preparing food product or healthcare food product for combating fatigue
TW201006389A (en) Formulations, methods and its use for reducing abdominal fat and waist circumference
JP7244945B2 (en) Uses of Antrodia cinnamomum to relieve drunkenness and/or increase alcohol metabolism
CN109846046A (en) A kind of mannose-amino acid complex improving immunity
KR20100088007A (en) A composition for preventing or treating of fatty liver comprising an extract of chestnut inner shell
WO2019100843A1 (en) Enteromorpha prolifera polysaccharide composite blood lipid-lowering health care product and preparation method therefor
JP2007031302A (en) Adiponectin production accelerator and metabolic syndrome preventive
CN107184598A (en) A kind of pet heart disease composite tablet
Chen et al. Anti-fatigue effect of aqueous extract of Anisomeles indica (L) Kuntze in mice
TWI440465B (en) Herbal extract mixture for reducing blood lipid and a combination thereof
CN111686236B (en) Capsule for dispelling effects of alcohol, protecting liver and protecting brain
KR20190069904A (en) Tablet-type composition for preventing and relieving hangover, and protecting hepatic caused by alcohol containing medical herbs
CN116849357B (en) Medicinal and edible composition with liver protection function and preparation method thereof
US20010055624A1 (en) Composition comprising panax pseudo ginseng, eucommiae ulmoides and polygonati rhizoma
TWI698244B (en) Use of a combination of small-molecule fucoidan and fucoxanthin for preparing a composition for improving non-alcoholic fatty liver
TW201806612A (en) Use of anisomeles indica in manufacture of medicament for anti-fatigue
JP7068803B2 (en) Pharmaceutical composition for reducing blood lipids
CN114159488A (en) Pharmaceutical composition and application thereof in field of improving anoxia tolerance
WO2005063228A1 (en) Glucose tolerance-improving agent